Matches in Wikidata for { <http://www.wikidata.org/entity/Q92086571> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q92086571 description "article scientifique publié en 2020" @default.
- Q92086571 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q92086571 description "scientific article published on 20 April 2020" @default.
- Q92086571 description "wetenschappelijk artikel" @default.
- Q92086571 description "наукова стаття, опублікована 20 квітня 2020" @default.
- Q92086571 name "Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system" @default.
- Q92086571 name "Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system" @default.
- Q92086571 type Item @default.
- Q92086571 label "Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system" @default.
- Q92086571 label "Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system" @default.
- Q92086571 prefLabel "Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system" @default.
- Q92086571 prefLabel "Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system" @default.
- Q92086571 P1433 Q92086571-2441D5F0-1AF5-4B70-BE3B-B26145A3DE04 @default.
- Q92086571 P1476 Q92086571-C51AC49A-3CA1-412E-BC87-0E42BBA765D2 @default.
- Q92086571 P2093 Q92086571-43F34E39-BD84-44D5-AE24-F63488A456AE @default.
- Q92086571 P2093 Q92086571-480493AB-0F56-4C3F-9609-D80DFDF7AF25 @default.
- Q92086571 P2093 Q92086571-92B6593C-C279-41FF-8E9A-2D057333C545 @default.
- Q92086571 P2093 Q92086571-BB80A200-2505-4632-9CFF-5F4924F76771 @default.
- Q92086571 P2093 Q92086571-D477AB20-E089-4EC2-AE59-84D7E89315C0 @default.
- Q92086571 P304 Q92086571-5098B135-5FD4-45EB-8DEC-3E41F0F987AD @default.
- Q92086571 P31 Q92086571-34C02704-1863-4380-833A-B1279786FD22 @default.
- Q92086571 P356 Q92086571-88684EB6-6539-466B-9024-7A7C2925A435 @default.
- Q92086571 P577 Q92086571-0BE83630-3255-40F5-81FA-4D315976D803 @default.
- Q92086571 P698 Q92086571-BB59DB27-1F39-4B70-A620-C54770D2BBF5 @default.
- Q92086571 P356 2047487320915663 @default.
- Q92086571 P698 32312089 @default.
- Q92086571 P1433 Q2493290 @default.
- Q92086571 P1476 "Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system" @default.
- Q92086571 P2093 "Emanuel Raschi" @default.
- Q92086571 P2093 "Fabrizio De Ponti" @default.
- Q92086571 P2093 "Igor Diemberger" @default.
- Q92086571 P2093 "Ippazio Cosimo Antonazzo" @default.
- Q92086571 P2093 "Milo Gatti" @default.
- Q92086571 P304 "2047487320915663" @default.
- Q92086571 P31 Q13442814 @default.
- Q92086571 P356 "10.1177/2047487320915663" @default.
- Q92086571 P577 "2020-04-20T00:00:00Z" @default.
- Q92086571 P698 "32312089" @default.